Your browser doesn't support javascript.
loading
Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans.
Franquet, Elisa; Palmer, Mathew R; Gifford, Anne E; Selen, Daryl J; Chen, Yih-Chieh S; Sedora-Roman, Neda; Joyce, Robin M; Kolodny, Gerald M; Moss, Alan C.
Afiliación
  • Franquet E; aDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology bDivision of Gastroenterology, Department of Medicine cDivision of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA dDepartment of Medicine, Universidad Autónoma de Barcelona (UAB), Barcelona, Spain.
Nucl Med Commun ; 35(10): 1026-31, 2014 Oct.
Article en En | MEDLINE | ID: mdl-25076161

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifamicinas / Radiofármacos / Fluorodesoxiglucosa F18 / Mucosa Intestinal / Intestinos / Antibacterianos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Nucl Med Commun Año: 2014 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifamicinas / Radiofármacos / Fluorodesoxiglucosa F18 / Mucosa Intestinal / Intestinos / Antibacterianos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Nucl Med Commun Año: 2014 Tipo del documento: Article País de afiliación: España